JefferyLorneKutokMD

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor of Pathology, Brigham and Women's Hospital

Are you Dr. Kutok?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Jeffery Kutok, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Brigham and Women's Hospital and is an Associate Professor of Pathology at Brigham and Women's Hospital.

Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
Stony Brook University Health Sciences Center School of MedicineClass of 1995
Brigham and Women's HospitalFellowship, Hematopathology

PubMed

EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.
Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang
Cancer Research. 2023-12-01
2 citations
EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.
Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang
Biorxiv. 2023-08-16
6 citations
Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
Vincent Gagné, Anne Aubry-Morin, Maria Plesa, Rachid Abaji, Kateryna Petrykey
Pharmacogenomics. 2019-11-05

Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual MeetingDecember 11th, 2021
Epizyme Hires Kutok as CSO to Find New Uses for TazverikMarch 20th, 2020
Chutes & Ladders—Bristol Myers Squibb Appoints Mily to Strategy LeadMarch 20th, 2020
Join now to see all